S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Top 5 AI Stocks to Buy for 2024 (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The only accurate crypto trading system I know … (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Did You Get Your Free Bitcoin Yet? (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Top 5 AI Stocks to Buy for 2024 (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The only accurate crypto trading system I know … (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Did You Get Your Free Bitcoin Yet? (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Top 5 AI Stocks to Buy for 2024 (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The only accurate crypto trading system I know … (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Did You Get Your Free Bitcoin Yet? (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Top 5 AI Stocks to Buy for 2024 (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The only accurate crypto trading system I know … (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Did You Get Your Free Bitcoin Yet? (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial
NASDAQ:SIOX

Sio Gene Therapies (SIOX) Stock Price, News & Analysis

→ Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad)
Free SIOX Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.45
▼
$0.48
50-Day Range
$0.38
▼
$0.48
52-Week Range
$0.25
▼
$0.50
Volume
40,400 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisSocial Media
SIOX stock logo

About Sio Gene Therapies Stock (NASDAQ:SIOX)

Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.

SIOX Stock News Headlines

February 2, 2024 | finance.yahoo.com
Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share
November 22, 2023 | morningstar.com
Sio Gene Therapies Inc SIOX
April 20, 2024 | Crypto Swap Profits (Ad)
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
November 1, 2023 | thestreet.com
Two Promising Gene Therapy Stocks Tackling Eye Disease
July 19, 2023 | fool.com
Sio Gene Therapies (NASDAQ: AXGT)
July 13, 2023 | finance.yahoo.com
Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion
May 23, 2023 | nbcnews.com
A new gene therapy could be a game-changer for patients with severe anemia. The cost? $2.8 million.
February 14, 2023 | finance.yahoo.com
Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
April 20, 2024 | Crypto Swap Profits (Ad)
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
January 26, 2023 | seekingalpha.com
SIOX Sio Gene Therapies Inc.
December 14, 2022 | finance.yahoo.com
Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution
November 10, 2022 | bizjournals.com
Following layoffs, gene therapy firm leaves Durham
November 10, 2022 | finance.yahoo.com
Sio Gene Therapies Announces Fiscal Second Quarter 2022 Financial Results
October 31, 2022 | finance.yahoo.com
Sio Gene Therapies (NASDAQ:SIOX) Will Have To Spend Its Cash Wisely
August 11, 2022 | finance.yahoo.com
Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results
August 5, 2022 | uk.finance.yahoo.com
Sio Gene Therapies Inc. (SIOX)
June 14, 2022 | bizjournals.com
Gene therapy firm in Durham slashes headcount as biotech stumbles
June 14, 2022 | finance.yahoo.com
Sio Gene Therapies Announces Fiscal Year 2021 Year-End Financial Results
April 28, 2022 | markets.businessinsider.com
Mid-Afternoon Market Update: Nasdaq Jumps 400 Points; Sio Gene Therapies Shares Plummet
April 28, 2022 | finance.yahoo.com
Sio Gene Therapies Ditches Two Remaining Programs, Seeks Buyer(s), Shares Plunge
April 27, 2022 | finance.yahoo.com
Sio Gene Therapies Provides Corporate Update
February 11, 2022 | finance.yahoo.com
Sio Gene Therapies Announces Corporate Updates and Fiscal Third Quarter 2021 Financial Results
February 2, 2022 | benzinga.com
SVB Leerink Downgrades Sio Gene Therapies to Market Perform, Lowers Price Target to $1
February 1, 2022 | benzinga.com
HC Wainwright & Co. Maintains Buy on Sio Gene Therapies, Lowers Price Target to $7
February 1, 2022 | msn.com
The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program
January 4, 2022 | nasdaq.com
Companies Like Sio Gene Therapies (NASDAQ:SIOX) Are In A Position To Invest In Growth
November 12, 2021 | finance.yahoo.com
We're Hopeful That Sio Gene Therapies (NASDAQ:SIOX) Will Use Its Cash Wisely
See More Headlines
Receive SIOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sio Gene Therapies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/12/2021
Today
4/19/2024
Fiscal Year End
3/31/2025
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SIOX
CUSIP
N/A
CIK
1636050
Web
siogtx.com
Phone
(646) 677-6770
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
No Data
Beta
1.14
Ten Starter Stocks For Beginners to Buy Now Cover
Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. David W. Nassif J.D. (Age 70)
    CEO, CFO, Chief Accounting Officer, General Counsel & Director
    Comp: $699.52k

Key Competitors

View All Competitors

SIOX Stock Analysis - Frequently Asked Questions

How were Sio Gene Therapies' earnings last quarter?

Sio Gene Therapies Inc. (NASDAQ:SIOX) released its quarterly earnings data on Friday, November, 12th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.17) by $0.12.

When did Sio Gene Therapies' stock split?

Sio Gene Therapies's stock reverse split on the morning of Wednesday, May 8th 2019. The 1-8 reverse split was announced on Tuesday, May 7th 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 7th 2019. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

This page (NASDAQ:SIOX) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets